Company AI Risk Explorer
Loading the data…
Welcome to the Company AI Risk Explorer

This tool maps what large global companies say in public about AI risk. We reviewed public documents from roughly 200 of the world's largest companies. We coded every risk they acknowledge against the AI Risk Repository taxonomy.

Filter by company, sector, AI role, or risk. Compare what companies acknowledge against expert ratings of severity, sector vulnerability, and role responsibility.

← Back to the overview Company AI Risk Explorer

Companies × risks

Johnson & Johnson

Johnson & Johnson deploys AI across drug development, robotic-assisted surgery, commercial activities, chatbots, and smart manufacturing. It also develops specialised AI for healthcare, including FDA-cleared AI-enabled MedTech products and proprietary surgical AI algorithms.

We reviewed 2 public documents from Johnson & Johnson and found it acknowledges 3 of 24 AI risks, including discrimination and capability & robustness.

Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing

Roles: AI deployer; Specialized AI developer

AI risks Johnson & Johnson acknowledges

  • Discrimination: “external influences, such as biases that exist in healthcare, may affect them... we can identify when and why it may produce biased results.” (Doing the Right Thing - AI & Ethics - Johnson & Johnson)
  • Capability & robustness: “We also acknowledge that the characteristics of data sets may change over time (called "drift"). This may require us to reexamine the data for new insights and evolve our models.” (Doing the Right Thing - AI & Ethics - Johnson & Johnson)
  • Transparency & interpretability: “When it is not possible to fully explain how an AI model works, we seek to design and monitor the AI model proactively...” (Doing the Right Thing - AI & Ethics - Johnson & Johnson)

Documents we reviewed